<?xml version="1.0" encoding="UTF-8"?>
<p>In a retrospective study in China that included 449 patients, patients who received a prophylactic dose of heparin when they had sepsis-induced coagulopathy (SIC) score â‰¥ 6 and a d-dimer level &gt;6-fold of upper limit of normal had decreased mortality (
 <xref rid="B81" ref-type="bibr">81</xref>). Based on the limited available data, the International Society of Thrombosis and Hemostasis (ISTH) recommends the measurement of d-dimer, PT, and platelet count for all patients with COVID-19 infection to help with risk stratification. The society also recommends the administration of low molecular weight heparin at prophylactic dose to all hospitalized patients with no contraindications (
 <xref rid="B114" ref-type="bibr">114</xref>). RCTs examining the use of heparin in COVID-19 patients are required to make appropriate recommendations.
</p>
